Ozan Pamir

Ozan Pamir

Chief Financial OfficeratNiagen Bioscience· In proxies 2024–2025

Pay in FY2025+55% from the year before · Niagen Bioscience stock +19.9% the same year

Ozan Pamir was paid $716.5K in FY2025 (Dec), up 55%. Niagen Bioscience stock rose 19.9% that year.

Pay$100 in the stock at the end of FY23 → $445
Pay is from the Summary Compensation Table of each Niagen Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Niagen BiosciencePublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role +74%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?